EHMT2 and glioblastoma: In vitro studies have shown that inhibition of EHMT2 in established GBM cell lines promoted GBM cell growth and increased expression of stem cell markers, and direct methylation of HIF-1α by EHMT2 inhibits hypoxia adaptation and cellular invasion (148, 149).